PTGS2 and neoplasm: In addition, previous studies have shown that tumor stromal cells contribute to COX-2 expression in CRC, indicating that normal and tumor cells may contribute to an increase in prostaglandin levels within the tumor microenvironment and the subsequent development of cancer (22).